BlackRock’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $591M | Buy |
2,961,923
+21,692
| +0.7% | +$4.29M | 0.01% | 978 |
|
|
2025
Q4 | $556M | Buy |
2,940,231
+55,704
| +2% | +$10.7M | 0.01% | 1023 |
|
|
2025
Q3 | $511M | Sell |
2,884,527
-29,214
| -1% | -$4.34M | 0.01% | 1071 |
|
|
2025
Q2 | $331M | Sell |
2,913,741
-6,494
| -0.2% | -$694K | 0.01% | 1303 |
|
|
2025
Q1 | $307M | Sell |
2,920,235
-25,849
| -0.9% | -$2.92M | 0.01% | 1329 |
|
|
2024
Q4 | $316M | Sell |
2,946,084
-53,548
| -2% | -$6.05M | 0.01% | 1397 |
|
|
2024
Q3 | $300M | Buy |
2,999,632
+128,136
| +4% | +$12.9M | 0.01% | 1417 |
|
|
2024
Q2 | $242M | Buy |
2,871,496
+3,226
| +0.1% | +$257K | 0.01% | 1497 |
|
|
2024
Q1 | $210M | Sell |
2,868,270
-94,044
| -3% | -$6.93M | ﹤0.01% | 1611 |
|
|
2023
Q4 | $212M | Buy |
2,962,314
+121,230
| +4% | +$7.15M | 0.01% | 1617 |
|
|
2023
Q3 | $170M | Sell |
2,841,084
-65,075
| -2% | -$4.28M | ﹤0.01% | 1649 |
|
|
2023
Q2 | $210M | Buy |
2,906,159
+67,497
| +2% | +$5.06M | 0.01% | 1542 |
|
|
2023
Q1 | $209M | Buy |
2,838,662
+48,898
| +2% | +$3.48M | 0.01% | 1502 |
|
|
2022
Q4 | $186M | Sell |
2,789,764
-1,483,222
| -35% | -$96.4M | 0.01% | 1590 |
|
|
2022
Q3 | $230M | Sell |
4,272,986
-62,884
| -1% | -$3.7M | 0.01% | 1365 |
|
|
2022
Q2 | $241M | Sell |
4,335,870
-45,621
| -1% | -$2.59M | 0.01% | 1383 |
|
|
2022
Q1 | $307M | Sell |
4,381,491
-15,230
| -0.3% | -$1.11M | 0.01% | 1342 |
|
|
2021
Q4 | $424M | Buy |
4,396,721
+18,617
| +0.4% | +$1.72M | 0.01% | 1162 |
|
|
2021
Q3 | $381M | Buy |
4,378,104
+1,100,966
| +34% | +$85.2M | 0.01% | 1210 |
|
|
2021
Q2 | $268M | Sell |
3,277,138
-131,454
| -4% | -$10.9M | 0.01% | 1551 |
|
|
2021
Q1 | $324M | Buy |
3,408,592
+257,100
| +8% | +$24.3M | 0.01% | 1367 |
|
|
2020
Q4 | $196M | Sell |
3,151,492
-272,692
| -8% | -$15.5M | 0.01% | 1636 |
|
|
2020
Q3 | $204M | Buy |
3,424,184
+13,553
| +0.4% | +$925K | 0.01% | 1375 |
|
|
2020
Q2 | $238M | Sell |
3,410,631
-129,652
| -4% | -$8.22M | 0.01% | 1236 |
|
|
2020
Q1 | $161M | Sell |
3,540,283
-283,125
| -7% | -$16M | 0.01% | 1325 |
|
|
2019
Q4 | $249M | Sell |
3,823,408
-118,218
| -3% | -$7.9M | 0.01% | 1318 |
|
|
2019
Q3 | $245M | Sell |
3,941,626
-64,119
| -2% | -$4.03M | 0.01% | 1256 |
|
|
2019
Q2 | $285M | Sell |
4,005,745
-385,281
| -9% | -$28.4M | 0.01% | 1159 |
|
|
2019
Q1 | $344M | Sell |
4,391,026
-36,237
| -0.8% | -$2.75M | 0.02% | 1009 |
|
|
2018
Q4 | $375M | Sell |
4,427,263
-937,026
| -17% | -$99.9M | 0.02% | 825 |
|
|
2018
Q3 | $919M | Buy |
5,364,289
+130,536
| +2% | +$19.7M | 0.04% | 454 |
|
|
2018
Q2 | $676M | Buy |
5,233,753
+402,585
| +8% | +$44.9M | 0.03% | 556 |
|
|
2018
Q1 | $498M | Buy |
4,831,168
+27,041
| +0.6% | +$2.67M | 0.02% | 708 |
|
|
2017
Q4 | $410M | Buy |
4,804,127
+82,168
| +2% | +$7.12M | 0.02% | 825 |
|
|
2017
Q3 | $401M | Buy |
4,721,959
+419,699
| +10% | +$33.2M | 0.02% | 801 |
|
|
2017
Q2 | $326M | Buy |
4,302,260
+110,426
| +3% | +$7.72M | 0.02% | 926 |
|
|
2017
Q1 | $277M | Buy |
4,191,834
+4,189,319
| +166,573% | +$276M | 0.02% | 1036 |
|
|
2016
Q4 | $159K | Sell |
2,515
-576
| -19% | -$36.3K | ﹤0.01% | 2286 |
|
|
2016
Q3 | $197K | Sell |
3,091
-4,603
| -60% | -$338K | ﹤0.01% | 2162 |
|
|
2016
Q2 | $572K | Buy |
7,694
+5,480
| +248% | +$407K | ﹤0.01% | 1623 |
|
|
2016
Q1 | $147K | Buy |
2,214
+1,379
| +165% | +$83.8K | ﹤0.01% | 1823 |
|
|
2015
Q4 | $56K | Sell |
835
-255
| -23% | -$15.7K | ﹤0.01% | 1988 |
|
|
2015
Q3 | $59K | Sell |
1,090
-9,604
| -90% | -$583K | ﹤0.01% | 1842 |
|
|
2015
Q2 | $673K | Buy |
10,694
+9,607
| +884% | +$524K | ﹤0.01% | 1477 |
|
|
2015
Q1 | $52K | Sell |
1,087
-1,055
| -49% | -$40.4K | ﹤0.01% | 1936 |
|
|
2014
Q4 | $71K | Buy |
2,142
+1,267
| +145% | +$41.2K | ﹤0.01% | 1825 |
|
|
2014
Q3 | $26K | Hold |
875
| – | – | ﹤0.01% | 2200 |
|
|
2014
Q2 | $34K | Sell |
875
-133
| -13% | -$5.4K | ﹤0.01% | 2107 |
|
|
2014
Q1 | $43K | Buy |
1,008
+304
| +43% | +$12.7K | ﹤0.01% | 1978 |
|
|
2013
Q4 | $23K | Sell |
704
-46
| -6% | -$1.5K | ﹤0.01% | 2293 |
|
|
2013
Q3 | $20K | Hold |
750
| – | – | ﹤0.01% | 2276 |
|
|
2013
Q2 | $18K | Buy |
+750
| New | +$13.5K | ﹤0.01% | 2350 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
BlackRock's LGND Position: Q1 2026 in Review
BlackRock increased its Ligand Pharmaceuticals (LGND) stake by 0.74% in Q1 2026, buying an estimated $4.29M and bringing the position to 2,961,923 shares worth $591M. The position accounts for 0.01% of the portfolio, ranked #978.
BlackRock first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $919M in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- BlackRock held 2,961,923 shares of Ligand Pharmaceuticals worth $591M as of Q1 2026.
- BlackRock bought 21,692 Ligand Pharmaceuticals shares in Q1 2026, an estimated $4.29M.
- Ligand Pharmaceuticals made up 0.01% of BlackRock's portfolio in Q1 2026, its #978 holding.
- BlackRock first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- BlackRock's Ligand Pharmaceuticals position peaked at $919M in Q3 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.